Dow Down 1.37% Nasdaq Down 1.61%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
10.14 Up 0.24(2.37%) 2:14PM EDT - Nasdaq Real Time Price
Prev Close:9.90
Open:9.80
Bid:10.05 x 200
Ask:10.08 x 300
1y Target Est:28.33
Beta:-0.64
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:9.75 - 10.18
52wk Range:8.46 - 27.25
Volume:488,363
Avg Vol (3m):910,708
Market Cap:234.21M
P/E (ttm):N/A
EPS (ttm):-1.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
RPRXUp 2.37%234.21M
ABTDown 0.91%61.97B
ACTDown 1.23%62.98B
AUXLUp 0.89%1.51B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.53
Quarterly EPS Est (Sep-14) :-0.39
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.31

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback